160.13
price up icon0.17%   0.27
 
loading

Johnson Johnson Azioni (JNJ) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.06%
21,383.00
21,395.00 21,351.00 21,519.00 20,894.00
Cost Of Revenue
4.22%
6,511.00
6,798.00 6,606.00 8,212.00 8,395.00
Gross Profit
1.88%
14,872.00
14,597.00 14,745.00 15,057.00 14,207.00
Operating Expenses
14.20%
11,158.00
9,771.00 9,528.00 8,751.00 15,494.00
Interest Income/Expense
2.65%
155.00
151.00 192.00 346.00 215.00
Benefits Costs and Expenses
6.64%
17,669.00
16,569.00 16,134.00 15,213.00 22,181.00
Costs And Expenses
6.64%
17,669.00
16,569.00 16,134.00 15,213.00 22,181.00
Operating Income/Loss
23.04%
3,714.00
4,826.00 5,217.00 6,306.00 -1,287.00
Income/Loss From Continuing Operations Before Tax
23.04%
3,714.00
4,826.00 5,217.00 6,306.00 -1,287.00
Income Tax Expense/Benefit, Deferred
35.24%
-1,562.00
-2,412.00 560.00 -799.00 -1,543.00
Income Tax Expense/Benefit
33.86%
459.00
694.00 908.00 1,618.00 -669.00
Income/Loss From Continuing Operations After Tax
21.22%
3,255.00
4,132.00 4,309.00 5,376.00 -491.00
Income/Loss From Discontinued Operations, Net Of Tax
100.00%
-
-83.00 21,719.00 -232.00 423.00
Net Income/Loss
19.61%
3,255.00
4,049.00 26,028.00 5,144.00 -68.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,820%
2,408.20
-42.10 2,522.90 2,598.40 2,605.50
Diluted Average Shares
5,751%
2,430.10
-43.00 2,549.70 2,625.70 2,605.50
Basic Earnings Per Share
19.64%
1.35
1.68 10.32 1.98 -0.03
Diluted Earnings Per Share
19.76%
1.34
1.67 10.21 1.96 -0.03
Common Stock Dividends
0.00%
1.19
1.19 1.19 1.19 1.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$203.55
price down icon 0.16%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
drug_manufacturers_general NVO
$111.94
price down icon 0.01%
$319.22
price down icon 0.29%
Capitalizzazione:     |  Volume (24 ore):